PARSIPPANY, N.J., July 16, 2024 — Zoetis announced today that Synovex® Primer™ is now available for cattle producers who need to increase weight gain in growing beef steers or heifers in the dry lot production phase. The Food and Drug Administration’s Center for Veterinary Medicine (CVM) approved Synovex Primer earlier this year, along with an updated label indication for Synovex Choice® in the dry lot.
Synovex Primer is a low-dose combination product with 50 mg of trenbolone acetate (TBA) and 7 mg of estradiol benzoate. Research demonstrated that Synovex Primer significantly increased average daily gain at 2.47 lbs./head/day (p = 0.0016) when compared with the sham implanted group at 2.21 lbs./head/day over the course of the 90-day study.1
“The addition of Synovex Primer to our implant portfolio gives producers options in the dry lot space,” said Bryan Bernhard, PhD, nutritionist with Zoetis beef strategic technical services. “From dry lot to pasture to confined feeding operations, the portfolio of Synovex implants allows beef producers to dial-in the dose of TBA over the animal’s lifetime and choose a Synovex implant that matches the available nutrition and performance goals.”
For more information on how the expanded label could fit your operation, please visit with your Zoetis sales representative. You also can visit www.Synovex.com to learn more.
Refer to individual labels for complete directions for use, precautions, and warnings. Reimplant only if and as directed in labeling.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.
